Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Interleukin 6 (IL6) is one of the major inflammation‐associated cytokines. Elevated serum or tissue levels of IL 6 have been reported to occur in several human diseases, including infections of the central nervous system (CNS), but not in non‐infectious CNS inflammation, e.g. multiple sclerosis. While studying experimental autoimmune encephalomyelitis (EAE) as an animal model for autoimmune inflammation of the CNS, we found increased IL 6 levels in the CNS of mice suffering from a lethal form of the disease. IL 6 levels in the spleens and sera were not significantly increased. These findings are indicative of local production of IL6 in the CNS during EAE, and represent the first demonstration of IL6 production in non‐infectious CNS inflammatory disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Houssiau, F. A., Devogelaer, J., Damme, J. V., Deuxchaisnes, C. N. D., & Snick, J. V. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310614 · Cited by 847
Self-citationFrei, K., Leist, T. P., Meager, A., Gallo, P., Leppert, D., Zinkernagel, R. M., & Fontana, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.1.449 · Cited by 245
Cited by
Interleukin-6, a Major Cytokine in the Central Nervous System
Erta, M., Quintana, A., & Hidalgo, J. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4679 · Cited by 1,087
Khoury, S. J., Hancock, W. W., & Weiner, H. L. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.5.1355 · Cited by 708
The influence of cytokines on the integrity of the blood-brain barrier in vitro
de Vries, H. E., Blom-Roosemalen, M. C. M., Oosten, M. V., de Boer, A. G., van Berkel, T. J. C., Breimer, D. D., & Kuiper, J. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00148-4 · Cited by 665
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
Yao, X., Huang, J., Zhong, H., Shen, N., Faggioni, R., Fung, M., & Yao, Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.004 · Cited by 664
Interleukin-6 (IL-6)—A molecule with both beneficial and destructive potentials
Gadient, R. A., & Otten, U. H. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00021-x · Cited by 481
Quintanilla, R. A., Orellana, D. I., González-Billault, C., & Maccioni, R. B. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.002 · Cited by 455
Samoilova, E. B., Horton, J. L., Hilliard, B., Liu, T.-S. T., & Chen, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6480 · Cited by 440
The Blood-Brain Barrier in Neuroinflammatory Diseases
de Vries, H. E., Kuiper, J., de Boer, A. G., Van Berkel, T. J. C., & Breimer, D. D. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01320-6 · Cited by 429
Physiological and pathological roles of interleukin-6 in the central nervous system
Gruol, D. L., & Nelson, T. E. (1997) · Molecular Neurobiology · doi:10.1007/bf02740665 · Cited by 404
Immunoregulators in the nervous system
Plata-Salamán, C. R. (1991) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80001-6 · Cited by 380
Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation
Petty, M. A., & Lo, E. H. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00128-4 · Cited by 360
Nervous tissue as an immune compartment: the dialect of the immune response in the CNS
Fabry, Z., Raine, C. S., & Hart, M. N. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90247-x · Cited by 357
Interleukin-6, a mental cytokine
Spooren, A., Kolmus, K., Laureys, G., Clinckers, R., De Keyser, J., Haegeman, G., & Gerlo, S. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.01.002 · Cited by 352
“There is some evidence that IL-6 levels are elevated in the serum and CSF of MS patients, locally around MS lesions and in experimental autoimmune encephalomyelitis (EAE) animal models (Frei et al., 1991; Gijbels et al., 1990; Maimone et al., 1991, 1997; Malmestrom et al., 2006; Navikas et al., 1996; Stelmasiak et al.…”
BackgroundResultGijbels, K., Galardy, R. E., & Steinman, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117578 · Cited by 339
Self-citationDisruption of central nervous system barriers in multiple sclerosis
Alvarez, J. I., Cayrol, R., & Prat, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.017 · Cited by 334
Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis
Maimone, D., Gregory, S., Arnason, B. G. W., & Reder, A. T. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90073-g · Cited by 333
Induction and regulation of interleukin-6 gene expression in rat astrocytes
Benveniste, E. N., Sparacio, S. M., Gavin Norris, J., Grennett, H. E., & Fuller, G. M. (1990) · Journal of Neuroimmunology · doi:10.1016/0165-5728(90)90104-u · Cited by 314
Merrill, J. E., Kono, D. H., Clayton, J., Ando, D. G., Hinton, D. R., & Hofman, F. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.2.574 · Cited by 297
Gene expression and function of interleukin I, interleukin 6 and tumor necrosis factor in the brain
Schöbitz, B., de Kloet, E. R., & Holsboer, F. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90034-5 · Cited by 285
Kim, J. S., Gautam, S. C., Chopp, M., Zaloga, C., Jones, M. L., Ward, P. A., & Welch, K. M. A. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00138-e · Cited by 283
Gijbels, K., Masure, S., Carton, H., & Opdenakker, G. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90192-n · Cited by 281
Self-citationRole of IL-6 in the regulation of neuronal development, survival and function
Kummer, K. K., Zeidler, M., Kalpachidou, T., & Kress, M. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155582 · Cited by 278
Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study
Lee, W.-J., Lee, S.-T., Moon, J., Sunwoo, J.-S., Byun, J.-I., Lim, J.-A., Kim, T.-J., Shin, Y.-W., Lee, K.-J., Jun, J.-S., et al. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0442-6 · Cited by 271
Yu, M., Johnson, J. M., & Tuohy, V. K. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1777 · Cited by 266
Therapeutic Targeting of the Interleukin-6 Receptor
Tanaka, T., Narazaki, M., & Kishimoto, T. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134715 · Cited by 262
Gadient, R. A., & Otten, U. (1994) · Brain Research · doi:10.1016/0006-8993(94)91211-4 · Cited by 194
IL-6 detection in multiple sclerosis brain
Maimone, D., Guazzi, G. C., & Annunziata, P. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00283-3 · Cited by 165
Qiu, Z., Sweeney, D. D., Netzeband, J. G., & Gruol, D. L. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-24-10445.1998 · Cited by 159
“Consistent with a role of IL-6 in pathological processes, elevated levels of IL-6 mRNA and protein occur in the CNS of animal models of neurodegenerative diseases (Gijbels et al., 1990; Grau et al., 1990; Minami et al., 1991).”
BackgroundLadenheim, B., Krasnova, I. N., Deng, X., Oyler, J. M., Polettini, A., Moran, T. H., Huestis, M. A., & Cadet, J. L. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1247 · Cited by 131
“Consistent with a role of IL-6 in neuropathological processes, elevated levels of IL-6 mRNA and protein have also been found in the CNS of animal models of neurodegenerative diseases (Gijbels et al., 1990; Grau et al., 1990).”
BackgroundOrellana, D. I., Quintanilla, R. A., Gonzalez-Billault, C., & Maccioni, R. B. (2005) · Neurotoxicity Research · doi:10.1007/bf03033983 · Cited by 76
Metadata
- Authors
- Gijbels, K., van Damme, J., Proost, P., Put, W., Carton, H., & Billiau, A.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1990-01
- Volume
- 20
- Issue
- 1
- Pages
- 233-235
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2029978823
- Cited by
- 148
- References
- 2
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.